Nordmark Arzneimittel GmbH & Co. KG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 2001-01-01
- Employees
- 501
- Market Cap
- -
Pepsin in Patients With Functional Dyspepsia
Completed
- Conditions
- DyspepsiaAbdominal PainVomitingFlatulenceFunctional Gastrointestinal DisordersNausea
- First Posted Date
- 2017-03-10
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Nordmark Arzneimittel GmbH & Co. KG
- Target Recruit Count
- 97
- Registration Number
- NCT03076411
- Locations
- 🇩🇪
Immanuel Krankenhaus, Berlin, Germany
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Phase 1
Completed
- Conditions
- Pancreatic InsufficiencyCystic FibrosisLung DiseasesRespiratory Tract DiseasesDigestive System Diseases
- Interventions
- Drug: Placebo (Caramel in sterile water)
- First Posted Date
- 2012-10-19
- Last Posted Date
- 2016-06-07
- Lead Sponsor
- Nordmark Arzneimittel GmbH & Co. KG
- Target Recruit Count
- 35
- Registration Number
- NCT01710644
- Locations
- 🇺🇸
Nemours Children's Clinic, Pensacola, Florida, United States
🇺🇸The University of Iowa, Iowa City, Iowa, United States
🇺🇸The Children's Medical Center of Dayton, Dayton, Ohio, United States
Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
Phase 1
Completed
- Conditions
- Ear DiseasesHearing LossHearing DisordersDeafnessHearing Loss, Sensorineural
- Interventions
- Drug: Saline solution
- First Posted Date
- 2012-06-18
- Last Posted Date
- 2018-12-21
- Lead Sponsor
- Nordmark Arzneimittel GmbH & Co. KG
- Target Recruit Count
- 31
- Registration Number
- NCT01621256
- Locations
- 🇨🇿
Site CZ, Praha, Czechia
🇩🇪Site D, München, Germany
© Copyright 2025. All Rights Reserved by MedPath